HCN News Team – Page 157 – Highly Capitalized

Wednesday, September 23, 2026 We Follow The Money.

About HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

BudLabs: The App Innovating How Cannabis Cultivators Measure Their Success

HCN News Team2024-09-24T08:38:08-08:00September 24th, 2024|Brands, Business|

LOS ANGELES — In cannabis cultivation, staying ahead of the ...

Out-of-State Applicants Dominate Minnesota’s Early Cannabis License Applications

HCN News Team2024-08-22T07:26:24-08:00August 22nd, 2024|Insights|

LOS ANGELES- Minnesota's newly established cannabis market is attracting significant ...

Bipartisan Lawmakers Push for MDMA Therapy for PTSD as FDA Decision Looms

HCN News Team2024-08-22T07:21:56-08:00August 22nd, 2024|Policy|

LOS ANGELES- In a rare show of bipartisanship, 80 members ...

Morocco Pardons 5,000 for Illegal Cannabis Cultivation in Push Toward Legal Market

HCN News Team2024-08-21T09:04:41-08:00August 21st, 2024|World|

LOS ANGELES- Morocco’s King Mohammed VI has pardoned nearly 5,000 ...

Willow Biosciences Posts Record Revenue in Q2

HCN News Team2024-08-21T09:01:41-08:00August 21st, 2024|Capital|

LOS ANGELES- Willow Biosciences Inc. a synthetic biology company specializing ...

New York Cannabis Market Report Highlights Progress and Challenges

HCN News Team2024-10-04T08:38:18-08:00October 4th, 2024|Insights|

LOS ANGELES- New York state officials released a comprehensive report ...

Week’s In Review: Federal Policy Uncertainty Continues to Challenge U.S. Cannabis Industry; LeafLink Acquires Leaf Trade to Enhance Cannabis Wholesale Platform; Canopy Growth Appoints New CEO Amid Financial Challenges; New York’s Legal Cannabis Sales Approach $1 Billion Milestone

HCN News Team2024-12-02T08:16:17-08:00December 2nd, 2024|Business, The Week in Review|

LOS ANGELES — Welcome to the far too-exciting world of ...

Week’s In Review: GOP Senator Calls for Comprehensive Cannabis Reform, Criticizes Partial Measures; MAPS Wins FDA Approval for Clinical Trials of Medical Cannabis; Curaleaf Secures Massachusetts’ First Cannabis Research License

HCN News Team2024-11-25T08:12:36-08:00November 25th, 2024|Business, The Week in Review|

LOS ANGELES — Welcome to the far too-exciting world of ...

Week’s In Review: How Do You Target the Right SEC-Accredited Investors in Cannabis?; Amethyst Health Secures Conditional Medical Cannabis License in New York; California’s Cannabis Excise Tax Set to Increase Amid Industry Concerns

HCN News Team2024-11-18T16:38:43-08:00November 18th, 2024|Business, The Week in Review|

LOS ANGELES — Welcome to the far too-exciting world of ...

Week’s In Review: Trump’s Return to Office: What it Means for the Cannabis Industry; Planet 13 Launches Initiative to Support Florida Veterans and First Responders with Medical Cannabis Access; Mixed Results for Cannabis Initiatives in U.S. States; Texas Voters Approve Local Cannabis Decriminalization in Dallas, Bastrop, and Lockhart

HCN News Team2024-11-11T01:54:51-08:00November 11th, 2024|Business, The Week in Review|

LOS ANGELES — Welcome to the far too-exciting world of ...

Previous 156157158 Next

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.